-
Delamanid is sold
under the
brand name Deltyba, is a
medication used to
treat tuberculosis.
Specifically it is used,
along with
other antituberculosis...
- pretomanid), OPC-67683 (now
delamanid), and R207910 (now bedaquiline), all of
which are in
Phase II of development.
Pretomanid and
delamanid are both in the nitroimidazole...
-
relationship of
different doses of
delpazolid in
combination with
bedaquiline delamanid moxifloxacin in
adult subjects with
newly diagnosed, uncomplicated, smear-positive...
- to
which mycolic acid
would be attached. This
mechanism is
shared with
delamanid.
Clinical isolates resistant to this drug tend to have
mutations in the...
- 2017 the drug was used in at
least 89 countries.
Another new drug is
delamanid,
which was
first approved by the
European Medicines Agency in 2013 to...
-
altered cording. An
international multi-centre
study has
proved that
delamanid (OPC-67683), a new
agent derived from the nitro-dihydro-imidazooxazole...
-
Ethambutol J04AK03
Terizidone J04AK04
Morinamide J04AK05
Bedaquiline J04AK06
Delamanid J04AK07
Amithiozone J04AK08
Pretomanid J04AM01
Streptomycin and isoniazid...
- (INN)
dehydroemetine (INN) Del-Vi-A
delafloxacin (USAN, INN)
Delalutin delamanid (USAN)
delandistrogene moxeparvovec (USAN, INN)
delandistrogene moxeparvovec-rokl...
-
redox potential,
which is
optimized for
specific biochemical pathway.
Delamanid, a drug used to
treat multi-drug-resistant
tuberculosis (MDRTB) in combination...
-
Trawling T.B.
Drugs Patents Case (Compulsory
Licensing of
Bedaquiline &
Delamanid)
Shapoorji Pallonji Group -
Pledging of Tata
Shares Invesco vs ZEEL, Punit...
